12/18
04:36 pm
incr
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Medium
Report
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
12/12
04:16 pm
incr
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
High
Report
InterCure (NASDAQ:INCR) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/3
08:30 am
incr
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation
Low
Report
InterCure and Cannasoul Sign Strategic Investment and Collaboration Agreements to Advance Cannabis Science and Pharmaceutical Innovation